WHITEHAWK THERAPEUTICS, INC. (WHWK)

4.62 -5.13% (-0.25)

Over 1Y: +161.0%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 3 4 5
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 0 Q3 '21 — Operating Cash Flow: -17.4M Q3 '21 — Free Cash Flow: -17.4M Q3 '21 — Net Income: -87.1M Q4 '21 — Revenue: 13.9M Q4 '21 — Operating Cash Flow: -12.4M Q4 '21 — Free Cash Flow: -12.5M Q4 '21 — Net Income: -16M Q1 '22 — Revenue: 2.3M Q1 '22 — Operating Cash Flow: -19.4M Q1 '22 — Free Cash Flow: -19.4M Q1 '22 — Net Income: -13.9M Q2 '22 — Revenue: 3.4M Q2 '22 — Operating Cash Flow: -10.7M Q2 '22 — Free Cash Flow: -11M Q2 '22 — Net Income: -18.3M Q3 '22 — Revenue: 4.2M Q3 '22 — Operating Cash Flow: -8.2M Q3 '22 — Free Cash Flow: -8.3M Q3 '22 — Net Income: -14.5M Q4 '22 — Revenue: 5.2M Q4 '22 — Operating Cash Flow: -11.3M Q4 '22 — Free Cash Flow: -11.4M Q4 '22 — Net Income: -13.9M Q1 '23 — Revenue: 5.9M Q1 '23 — Operating Cash Flow: -21.3M Q1 '23 — Free Cash Flow: -22.7M Q1 '23 — Net Income: -15.2M Q2 '23 — Revenue: 6.2M Q2 '23 — Operating Cash Flow: -16.8M Q2 '23 — Free Cash Flow: -17.4M Q2 '23 — Net Income: -18M Q3 '23 — Revenue: 6M Q3 '23 — Operating Cash Flow: -12M Q3 '23 — Free Cash Flow: -13M Q3 '23 — Net Income: -16.3M Q4 '23 — Revenue: 6.3M Q4 '23 — Operating Cash Flow: -9.6M Q4 '23 — Free Cash Flow: -10.5M Q4 '23 — Net Income: -16.3M Q1 '24 — Revenue: 5.4M Q1 '24 — Operating Cash Flow: -19.7M Q1 '24 — Free Cash Flow: -20.4M Q1 '24 — Net Income: -18.3M Q2 '24 — Revenue: 6.2M Q2 '24 — Operating Cash Flow: -9.2M Q2 '24 — Free Cash Flow: -9.7M Q2 '24 — Net Income: -14.6M Q3 '24 — Revenue: 7.2M Q3 '24 — Operating Cash Flow: -15.7M Q3 '24 — Free Cash Flow: -15.9M Q3 '24 — Net Income: -12.5M Q4 '24 — Revenue: 7.2M Q4 '24 — Operating Cash Flow: -15.1M Q4 '24 — Free Cash Flow: -15.2M Q4 '24 — Net Income: -18.3M Q1 '25 — Revenue: 7.1M Q1 '25 — Operating Cash Flow: -11.9M Q1 '25 — Free Cash Flow: -12.4M Q1 '25 — Net Income: 73M Q2 '25 — Revenue: 0 Q2 '25 — Operating Cash Flow: -53M Q2 '25 — Free Cash Flow: -53M Q2 '25 — Net Income: -52.6M Q3 '25 — Revenue: 0 Q3 '25 — Operating Cash Flow: -15.4M Q3 '25 — Free Cash Flow: -15.4M Q3 '25 — Net Income: -17.7M Q4 '25 — Revenue: 0 Q4 '25 — Operating Cash Flow: -17.2M Q4 '25 — Free Cash Flow: -17.2M Q4 '25 — Net Income: -23.3M Q1 '26 — Revenue: 0 Q1 '26 — Operating Cash Flow: -22.2M Q1 '26 — Free Cash Flow: -22.2M Q1 '26 — Net Income: -22.2M Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -14.5M Q2 '26 — Free Cash Flow: -14.5M Q2 '26 — Net Income: -16.6M -70M -35M 0 35M 70M 105M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
Accruals -5.4%
ROA -41.2%
ROCE -47.0%
ROE -43.6%
Asset turnover —
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —
SBC / sales —

0 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.4
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.4
Current ratio 17.4×
ND/EBITDA —
Cash runway 2.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 17.4×
F-score 3.4 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -15.5%
Sales/sh Y/Y -100.0%
Div. growth -100.0%
Shares change +129.1%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales Q/Q —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.